Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical: Archive
Teladoc Health (TDOC) Q1 Loss Widens on Decline in Visits
by Zacks Equity Research
Teladoc Health's (TDOC) Q1 results suffer from weak contributions from the BetterHelp unit. Management expects U.S. Integrated Care Members of 92-94 million for 2024, up from the prior mentioned 90-92 million.
HCAPositive Net Change CNCPositive Net Change TDOCPositive Net Change EHCPositive Net Change
earnings medical
GE HealthCare (GEHC) Q1 Earnings In Line, Sales Volume Decline
by Zacks Equity Research
GE HealthCare's (GEHC) first-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
ECLPositive Net Change BDXPositive Net Change ALGNNegative Net Change GEHCPositive Net Change
earnings medical medical-devices
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
by Zacks Equity Research
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change DXCMPositive Net Change
earnings medical medical-devices
QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements.
BSXPositive Net Change ALGNNegative Net Change DXCMPositive Net Change QGENPositive Net Change
earnings medical medical-devices
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
XRAYNo Net Change BPMCPositive Net Change NVCRNegative Net Change SIBNPositive Net Change
medical medical-devices
Analyzing How You Should Play Cigna (CI) Ahead of Q1 Earnings
by Zacks Equity Research
The first-quarter results of Cigna (CI) are likely to reflect expanding commercial middle market memberships and growth in Cigna Healthcare profits.
CIPositive Net Change FMSNegative Net Change AFMDNegative Net Change IGMSNegative Net Change
earnings medical
Pick These 4 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. NFLX, LEVI, BRBR and AEM are sound enough to meet financial obligations.
NFLXPositive Net Change AEMNegative Net Change LEVIPositive Net Change BRBRPositive Net Change
basic-materials consumer-discretionary medical retail
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
by Zacks Equity Research
Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.
REGNPositive Net Change PFENegative Net Change NVOPositive Net Change AMGNPositive Net Change MRNANegative Net Change
biotechs earnings gene-therapy immuno-therapy medical messenger-rna pharmaceuticals vaccines
Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.
PRGONegative Net Change SRPTPositive Net Change ARGXPositive Net Change AKRONegative Net Change
earnings medical
Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
by Debanjana Dey
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.
ARAYNegative Net Change SRDXNegative Net Change CORPositive Net Change GKOSPositive Net Change
earnings medical medical-devices
Why Sarepta (SRPT) Might Surprise This Earnings Season
by Zacks Equity Research
Sarepta (SRPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
SRPTPositive Net Change
genetic-testing medical
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
by Zacks Equity Research
An increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided Regeneron (REGN) in partially offsetting the decline in Eylea sales.
REGNPositive Net Change SNYPositive Net Change RHHBYPositive Net Change
biotechnology earnings-preview medical
Here's Why You Should Buy Bruker (BRKR) Stock Right Now
by Zacks Equity Research
Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.
DXCMPositive Net Change HCAPositive Net Change BRKRPositive Net Change INSPNegative Net Change
medical medical-devices
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Vertex's (VRTX) revenues in the first quarter of 2024 are likely to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
ALNYPositive Net Change VRTXPositive Net Change CRSPNegative Net Change ALPNPositive Net Change
biotechnology biotechs crispr earnings gene-editing gene-therapy medical pharmaceuticals
Company News for Apr 30, 2024
by Zacks Equity Research
Companies In The News Are: DPZ, BEN, ON, RVTY.
BENNegative Net Change DPZNegative Net Change ONPositive Net Change RVTYPositive Net Change
finance medical restaurants semiconductor
Top Stocks to Buy with Rising EPS Estimates After Earnings
by Shaun Pruitt
These companies saw their stocks spike after impressively beating earnings expectations last week and more upside could be ahead considering EPS estimates for fiscal 2024 have trended higher afterwards.
VLONegative Net Change RMDNegative Net Change AEMNegative Net Change APPFPositive Net Change
basic-materials earnings gold inflation investing medical medical-devices oil-energy tech-stocks
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
by Zacks Equity Research
Novo Nordisk's (NVO) revenues in the first quarter of 2024 are expected to have been driven by its diabetes and obesity care product sales, especially Ozempic, Rybelsus and Wegovy.
NVOPositive Net Change LLYPositive Net Change CTLTPositive Net Change OMGANegative Net Change
biotechnology earnings-preview medical
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
by Zacks Equity Research
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.
BSXPositive Net Change ALGNNegative Net Change RMDNegative Net Change AVTRNegative Net Change
earnings medical medical-devices
Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings
by Zacks Equity Research
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
BDXPositive Net Change UHSPositive Net Change THCPositive Net Change BPMCPositive Net Change
earnings medical medical-devices
Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.
ECLPositive Net Change BDXPositive Net Change ALGNNegative Net Change RVTYPositive Net Change
earnings medical medical-devices
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
by Zacks Equity Research
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
CAHPositive Net Change EWPositive Net Change NVCRNegative Net Change SIBNPositive Net Change
medical medical-devices
How You Should Play Hologic (HOLX) Ahead of Q2 Earnings
by Riya Anand
Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.
HOLXPositive Net Change INSPNegative Net Change TMDXNegative Net Change HITINegative Net Change
earnings-preview medical medical-devices
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Investors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
MRKPositive Net Change MRNANegative Net Change SRPTPositive Net Change ARGXPositive Net Change
biotechs earnings medical messenger-rna pharmaceuticals vaccines
Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid
by Zacks Equity Research
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.
ECLPositive Net Change BDXPositive Net Change IDXXPositive Net Change BRKRPositive Net Change
medical
Baxter (BAX) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
BAXNegative Net Change ZBHPositive Net Change LNTHPositive Net Change VERUNegative Net Change
medical medical-devices